Catalyst Wire Dossier Catalyst Wire Dossier

ERRIN

NORETHINDRONE · Mayne Pharma Inc.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for ERRIN, covering 2011-06-10 to 2025-10-10. Get the full timeline:

Most recent: FDA Approved: ERRIN — Supplemental Application (Mayne Pharma Inc.)

See pricing